Effects of continual intermittent administration of parathyroid hormone on implant stability in the presence of osteoporosis: an in vivo study using resonance frequency analysis in a rabbit model
J. appl. oral sci
; J. appl. oral sci;25(5): 498-505, Sept.-Oct. 2017. tab, graf
Article
de En
| LILACS, BBO
| ID: biblio-893658
Bibliothèque responsable:
BR1.1
ABSTRACT
Abstract Objective:
This study aimed to evaluate the effects of continual intermittent administration of parathyroid hormone (PTH) on implant stability in the presence of osteoporosis, using rabbit models. Material andMethods:
Fifteen female New Zealand white rabbits underwent ovariectomy and were administered glucocorticoids to induce osteoporosis, following which they were divided into three groups. The first group received intermittent subcutaneous PTH for 4 weeks until implant placement (PTH1), while the second and third groups received PTH (PTH2) and saline (control), respectively, for 4 weeks before and after implant placement. After intermittent administration of PTH or saline, titanium implants were inserted into the left femoral epiphyses of all animals, and the implant stability quotient (ISQ) was measured immediately after placement to assess the primary stability and at 2 and 4 weeks after implant placement to assess osseointegration. At 4 weeks after implant placement, histological and histomorphometric evaluations were conducted and the bone area around the implant socket was measured as a ratio of the total bone area to the total tissue area.Results:
Regarding primary stability, the ISQ values for the PTH1 and PTH2 groups were significantly higher than those for the control group (p<0.05). Concerning osseointegration, the ISQ values at 2 and 4 weeks were significantly higher for the PTH2 group than for the PTH1 and control (p<0.05) groups. Histological assessments showed a thicker and more trabecular bone around the implant sockets in the PTH2 specimens than in the PTH1 and control specimens. The bone area around the implant socket was significantly greater in the PTH2 group than in the PTH1 and control groups (p<0.05).Conclusions:
Our results suggest that continual intermittent PTH administration before and after dental implant placement is effective for the achievement of favorable stability and osseointegration in the presence of osteoporosis.Mots clés
Texte intégral:
1
Indice:
LILACS
Sujet Principal:
Ostéoporose
/
Hormone parathyroïdienne
/
Implants dentaires
/
Ostéo-intégration
/
Agents de maintien de la densité osseuse
Type d'étude:
Evaluation_studies
/
Prognostic_studies
Limites du sujet:
Animals
langue:
En
Texte intégral:
J. appl. oral sci
Thème du journal:
ODONTOLOGIA
Année:
2017
Type:
Article